Back
Cerus 10K Form
Sell
38
CERS
Cerus
Last Price:
$1.42
Seasonality Move:
0.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | CERS/Cerus Quarterly |
| 2023-11-02 | 10Q | CERS/Cerus Quarterly |
| 2023-08-03 | 10Q | CERS/Cerus Quarterly |
| 2023-05-04 | 10Q | CERS/Cerus Quarterly |
| 2022-11-03 | 10Q | CERS/Cerus Quarterly |
| 2022-08-04 | 10Q | CERS/Cerus Quarterly |
Receive CERS News And Ratings
See the #1 stock for the next 7 days that we like better than CERS
CERS Financial Statistics
Sales & Book Value
| Annual Sales: | $180.3M |
|---|---|
| Cash Flow: | $4M |
| Price / Cash Flow: | 31.19 |
| Annual Sales: | $0.30 |
| Price / Book: | 4.77 |
Profitability
| EPS (TTM): | -0.11000 |
|---|---|
| Net Income (TTM): | $-20.9M |
| Gross Margin: | $99.5M |
| Return on Equity: | -39.46% |
| Return on Assets: | -10.86% |
Cerus Earnings Forecast
Key Cerus Financial Ratios
-
The Gross Profit Margin over the past 28 years for CERS is 55.21%.
-
The Selling, General & Administrative Expenses for CERS have been equal to 42.10% of Gross Profit Margin.
-
The Research & Development expenses have been 32.68% of Revenue.
-
The Net Earning history of CERS is -11.60% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 16 years.
Cerus Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | CERS |
| CUSIP: | 157085 |
| Website: | cerus.com |
Debt
| Debt-to-Equity Ratio: | 1.5 |
|---|---|
| Current Ratio: | 2.39 |
| Quick Ratio: | 1.73 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |